Contribution: Industrial Research Assistance Program – Contributions to Firms
Fluid Biotech Inc.
$100,000.00
Determining In Vitro and In Vivo Absorption and Flow Diversion Characteristics of a Novel Bioabsorbable Stent for Aneurysms.
FY 2020-21 · 2020-08-01
Summary
For this IRAP project proposal, we will leverage our recently awarded MITACS funding to complete research and development studies on the absorption and flow diversion characteristics of our novel self-expandable bioabsorbable stent.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Calgary|Calgary, Alberta, Canada
Recipient Type
For-profit organization
Business Number
707314092
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2021-04-30
Agreement Number
955222
Agreement Start Date
2020-08-01
Agreement Title
Determining In Vitro and In Vivo Absorption and Flow Diversion Characteristics of a Novel Bioabsorbable Stent for Aneurysms.
Agreement Title (French)
Détermination des caractéristiques d'absorption et de détournement de flux in vitro et in vivo d'une nouvelle endoprothèse bioabsorbable pour anévrismes
Agreement Type
Contribution
Agreement Value
$100,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
For this IRAP project proposal, we will leverage our recently awarded MITACS funding to complete research and development studies on the absorption and flow diversion characteristics of our novel self-expandable bioabsorbable stent.
Description (French)
Pour cette proposition de projet du PARI, nous utiliserons le financement MITACS récemment accordé pour mener à bien des études de recherche et développement sur les caractéristiques d'absorption et de détournement de flux de notre nouvelle endoprothèse auto-expansible et bioabsorbable.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Confederation
Federal Riding (French)
Calgary Confederation
Federal Riding Number
48005
NAICS Code
3391
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
707314092
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
Fluid Biotech Inc.
Recipient Operating Name
Fluid Biotech Inc.
Recipient Postal Code
T2L 1Y8
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2020-2021-Q2-955222
